Jennifer Buell - Sep 29, 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Chief Executive Officer, Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact for Jennifer S. Buell
Stock symbol
INKT
Transactions as of
Sep 29, 2023
Transactions value $
-$151,419
Form type
4
Date filed
10/3/2023, 09:15 PM
Previous filing
Sep 29, 2023
Next filing
Oct 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Tax liability -$28.8K -25K -2.32% $1.15 1.05M Sep 29, 2023 Direct F1
transaction INKT Common Stock Tax liability -$61.2K -58.6K -5.57% $1.04 993K Oct 2, 2023 Direct F2
transaction INKT Common Stock Tax liability -$61.4K -65K -6.55% $0.94 928K Oct 3, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.99 to $1.20. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.875 to $1.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.